![Francois-Xavier Frapaise](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francois-Xavier Frapaise
Direttore Tecnico/Scientifico/R&S presso Abbotts Ltd.
Provenienza dei contatti di primo grado di Francois-Xavier Frapaise
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
TAP Pharmaceutical Products, Inc.
![]() TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL.
8
| Joint Venture | Pharmaceuticals: Major | 8 |
Abbotts Ltd.
![]() Abbotts Ltd. Real Estate DevelopmentFinance Abbotts Ltd. is a British company that provides real estate services. The private company is based in Clacton On Sea, UK. The CEO of the company is Harry Douglas Hill.
1
| Private Company | Real Estate Development | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Francois-Xavier Frapaise tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
HERON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | General Counsel | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
VERICEL CORPORATION | Pharmaceuticals: Major | Chairman | |
QuatRx Pharmaceuticals Co.
![]() QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Founder | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Santarus, Inc.
![]() Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
RIGHTMOVE PLC | Real Estate Development | Director/Board Member | |
Q Therapeutics, Inc.
![]() Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Director/Board Member | |
EAGLE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
REBUS HOLDINGS, INC. | Biotechnology | Chairman | |
Metabolic Solutions Development Co. LLC
![]() Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Pharmaceuticals: Generic | Director/Board Member | |
NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Director/Board Member | |
Edgemont Pharmaceuticals LLC
![]() Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member | |
ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Chief Executive Officer | |
Indiana University Foundation, Inc.
![]() Indiana University Foundation, Inc. Investment Trusts/Mutual FundsMiscellaneous Indiana University Foundation provides financial support to education and charitable causes. The company was founded in 1936 and is headquartered in Bloomington, IN. | Investment Trusts/Mutual Funds | Director/Board Member | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Graduate Degree Doctorate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
Morehouse College | College/University | Undergraduate Degree | |
Hormos Medical Oy
![]() Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Toledo Medical Center | College/University | Doctorate Degree | |
Boys & Girls Clubs of America
![]() Boys & Girls Clubs of America Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of America offers school programs. The firm's programs include character and leadership, education and career, health & life skills, the arts, sports, fitness and recreation. Boys & Girls Clubs of America was founded in 1860 and is headquartered in Atlanta, GA. | Miscellaneous Commercial Services | Director/Board Member | |
Universidad Nacional Autónoma de México | College/University | Undergraduate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
![]() Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Velcera LLC
![]() Velcera LLC Pharmaceuticals: MajorHealth Technology Velcera LLC operates as a pharmaceutical company. It focuses on innovation in the expanding pet health market and its product development targets pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products. The firm is developing Promist, a transmucosal oral mist drug delivery technology for use in companion animals. It is also developing Promist products, including VEL504 for pain management and VEL502 for treating allergic atopic dermatitis in canines. The company was founded ion February 18, 2010 and is headquartered in Yardley, PA. | Pharmaceuticals: Major | Director/Board Member | |
Lilly Research Center Ltd.
![]() Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Pharmaceuticals: Major | General Counsel | |
Parke, Davis & Co. LLC | Chief Tech/Sci/R&D Officer | ||
Takeda Pharmaceuticals International, Inc.
![]() Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
Laboratorios Sanfer SA de CV
![]() Laboratorios Sanfer SA de CV Pharmaceuticals: MajorHealth Technology Laboratorios Sanfer SA de CV manufactures and supplies pharmaceutical products. Its brands include Alquimid, Andantol, Astelin, Clavulin, Coversyl and Daflon. The company was founded by Santovena and Fernandez in 1941 and is headquartered in Mexico City, Mexico. | Pharmaceuticals: Major | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
The Indiana University School of Medicine | College/University | Doctorate Degree | |
Lavanda Ventures Ltd.
![]() Lavanda Ventures Ltd. Real Estate DevelopmentFinance Lavanda Ventures Ltd. operates as a full service property management and lettings agency. The firm provides an online rental platform for residential services, which allows landlords and homeowners to let their properties on websites. It markets the property as a short, medium and long-term let across all major platforms from Rightmove and Zoopla to Airbnb and Booking.com to ensure maximum occupancy and optimal returns. The company was founded by Guy Westlake and Frank Breckner in 2014 and is headquartered in London, the United Kingdom. | Real Estate Development | Chairman | |
Glenhawk Group Ltd.
![]() Glenhawk Group Ltd. Finance/Rental/LeasingFinance Glenhawk Group Ltd. is a British bridging loan company that offers short-term commercial property finance and bridging loans ranging from £100,000 to £10,000,000. Glenhawk is based in London, UK, and offers its services to clients in the United Kingdom. Glenhawk's bridging loans are fast, manageable, and reliable, with a swift credit approval process. The private company treats every project, development, and investment purchase as if it were their own. The company was founded in 2018 and has recently launched a new two-year property investment product to bridge the gap between property purchases. | Finance/Rental/Leasing | Director/Board Member | |
Glenhawk Financial Services Ltd.
![]() Glenhawk Financial Services Ltd. Finance/Rental/LeasingFinance Part of Glenhawk Group Ltd., Glenhawk Financial Services Ltd. is a bridging loan company based in London, UK. The British company offers short-term commercial property finance and bridging loans ranging from £100,000 to £10,000,000. Glenhawk's loans are fast, manageable, and reliable, treating every project, development, and investment purchase as if it were their own. The company also offers second charge bridging loans, allowing customers to raise money instead of re-mortgaging. Recently, Glenhawk announced the launch of a new two-year property investment product, as it continues growth towards £1billion of annual lending. As lenders using their own capital, Glenhawk can act quickly to bridge the gap between property purchases, whether it's a new apartment block or a quick refurbishment. The company was founded by Guy William Alexander Harrington, who has been the CEO since incorporation. | Finance/Rental/Leasing | Director/Board Member | |
MAGiQ Therapeutics, Inc.
![]() MAGiQ Therapeutics, Inc. BiotechnologyHealth Technology MAGiQ Therapeutics, Inc. develops biotechnologies and therapeutics. | Biotechnology | Director/Board Member | |
P. E. Grebow Consulting, Inc. | Founder | ||
New York University School of Medicine | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 40 |
Regno Unito | 7 |
Messico | 3 |
Canada | 2 |
Francia | 2 |
Settori
Health Technology | 31 |
Consumer Services | 11 |
Finance | 5 |
Commercial Services | 3 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 121 |
Corporate Officer/Principal | 57 |
Independent Dir/Board Member | 24 |
Chief Executive Officer | 21 |
President | 18 |
Contatti più connessi
Insiders | |
---|---|
Henry McKinnell | 35 |
Alain B. Schreiber | 25 |
Harry Hill | 24 |
Robert Zerbe | 18 |
Pedro Lichtinger | 16 |
H. Watkins | 15 |
Richard Daly | 15 |
Peter E. Grebow | 12 |
Linda E. Amper | 11 |
Kate C. Liebelt | 11 |
Helen Giza | 11 |
Shinji Honda | 10 |
Kevin P. Poulos | 6 |
Eugene Sun | 6 |
E. David Ballard | 5 |
- Borsa valori
- Insiders
- Francois-Xavier Frapaise
- Connessioni Società